Because they haven’t got FDA approval yet. This has been covered a few times on here. Clearly one or two large holders have used the recent good news to offload shares. Funds aren’t going to buy into this until risk from their end has been reduced ( which it will should approvals be processed)
EMV Price at posting:
$1.83 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)